Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL).
Br J Cancer
; 125(2): 306, 2021 Jul.
Article
in En
| MEDLINE
| ID: mdl-34012035
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
Language:
En
Journal:
Br J Cancer
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: